Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

DDO-7263

🥰Excellent
Catalog No. T60487Cas No. 2254004-96-9

DDO-7263 is a 1,2,4-Oxadiazole derivative that upregulates Nrf2 through binding to Rpn6 to block the assembly of 26S proteasome and the subsequent degradation of ubiquitinated Nrf2. DDO-7263 is a potent Nrf2 activator that activates the Nrf2-ARE signaling pathway and exerts anti-inflammatory activity [1].

DDO-7263

DDO-7263

🥰Excellent
Purity: 99.75%
Catalog No. T60487Cas No. 2254004-96-9
DDO-7263 is a 1,2,4-Oxadiazole derivative that upregulates Nrf2 through binding to Rpn6 to block the assembly of 26S proteasome and the subsequent degradation of ubiquitinated Nrf2. DDO-7263 is a potent Nrf2 activator that activates the Nrf2-ARE signaling pathway and exerts anti-inflammatory activity [1].
Pack SizePriceAvailabilityQuantity
1 mL x 10 mM (in DMSO)$98In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "DDO-7263"

Select Batch
Purity:99.75%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
DDO-7263 is a 1,2,4-Oxadiazole derivative that upregulates Nrf2 through binding to Rpn6 to block the assembly of 26S proteasome and the subsequent degradation of ubiquitinated Nrf2. DDO-7263 is a potent Nrf2 activator that activates the Nrf2-ARE signaling pathway and exerts anti-inflammatory activity [1].
In vitro
DDO-7263 (20 μM; 2-24 h) can upregulate the protein levels of NQO1 and HO-1. DDO-7263 (2.5, 5, 10, 20, 40, 80 μM; 24 h) can upregulate the survival rate of THP-Ms and PC12 cell after treatment of 400μM H2O2 in a concentration-dependent manner. DDO-7263 has no significant decrease on cell survival rate[1].
In vivo
DDO-7263 (10-100 mg/kg/day; IP; for 10 days) ameliorates MPTP-induced behavioral abnormalities in mice, significantly reduces chemically induced dopaminergic neuron loss of tyrosine hydroxylase (TH) in the substantia nigra (SN) and striatum of the mouse brain, and inhibits inflammatory factor secretion. DDO-7263 (7, 35, 70 mg/kg; IP) has a T1/2 of 3.32 hours and a Cmax of 1.38 mg/mL in rats[1].
Chemical Properties
Molecular Weight273.24
FormulaC14H9F2N3O
Cas No.2254004-96-9
SmilesCc1ccc(cn1)-c1noc(n1)-c1ccc(F)c(F)c1
Storage & Solubility Information
StorageShipping with blue ice.
Solubility Information
DMSO: 16.1 mg/mL (58.8 mM), Sonication and heating to 60℃ are recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.6598 mL18.2989 mL36.5979 mL182.9893 mL
5 mM0.7320 mL3.6598 mL7.3196 mL36.5979 mL
10 mM0.3660 mL1.8299 mL3.6598 mL18.2989 mL
20 mM0.1830 mL0.9149 mL1.8299 mL9.1495 mL
50 mM0.0732 mL0.3660 mL0.7320 mL3.6598 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy DDO-7263 | purchase DDO-7263 | DDO-7263 cost | order DDO-7263 | DDO-7263 chemical structure | DDO-7263 in vivo | DDO-7263 in vitro | DDO-7263 formula | DDO-7263 molecular weight